This latest contract joins a growing roster of industry giants, including Amgen, Biogen, Eli Lilly and Company, and Regeneron, that have transitioned to the platform. By deploying agentic capabilities—such as the Agentic Call Report—the system automates the generation of commercial evidence, allowing teams to identify treatment barriers and refine engagement strategies with healthcare professionals.

"We are establishing a fundamentally new way of working that helps bring medicines to patients faster and more efficiently," said Arno Sosna, president of Veeva’s CRM Suite. The platform functions as the central hub for the Veeva Vault CRM Suite, aligning sales, marketing, and medical departments to ensure compliant and customer-centric interaction across all communication channels.